Copy
CDCN Monthly Newsletter - December 20, 2016
Accelerating Research & Treatment for Castleman Disease
View this email in your browser
THE ACCELERATOR: CDCN'S NEWSLETTER 
December 2016
2nd Annual Quest for a Cure Gala a Huge Success! 
The 2nd Annual Quest for a Cure Gala for Castleman disease was incredible! Over 300 guests from the Castleman disease and Philadelphia communities joined together to raise funds and awareness to accelerate research and treatment to save lives.

Thanks to our guests, sponsors, and auction item donors, the Gala raised over $100,000 for life-saving research! Check out our studies at www.cdcn.org/research-pipelineIf you were unable to attend, but are still interested in contributing, please donate here!

Help Make This Video Viral!  
Please check out the following video and share it with your friends and family to raise awareness about the most deadly, most common disease that you (the public) have never heard of! As common as ALS and as deadly as lymphoma, Castleman disease needs research and progress. Our laser-focused approach is highly efficient and a model for rare disease research, but we need your support to help to cure this disease. Go to https://youtu.be/9PcJscr5xT8 or click below.
CDCN Recognized with Multiple Awards in 2016!
The World Affairs Council of Philadelphia presented its inaugural Young Friends Atlas Award to Dr. David Fajgenbaum in honor of his achievements as the Co-Founder and Executive Director of the Castleman Disease Collaborative Network. The 2016 Atlas Award was also presented to the Hon. Joseph R. Biden, Vice President of the United States, in recognition of his historic and visionary leadership in the fight against cancer. Fajgenbaum's father (David), Fajgenbaum, Vice President Biden, Managing Director of Communications, Caitlin Fajgenbaum, Community Coordinator, Patty Prazenica, and CDCN Advisory Council member, Bernie Prazenica are in the photograph below.
 
 
Dr. David Fajgenbaum was also awarded the 2016 RareVoice Federal Patient Advocacy Award by The EveryLife Foundation for Rare Diseases, which is dedicated to accelerating biotech innovation for rare disease treatments through science-driven public policy. CDCN Managing Director of Development, Mary Zuccato, Fajgenbaum, and Chief Strategic Officer, Wes Kaupinen are photographed below.
 
Support CDCN by shopping on Amazon Smile!
Amazon users can support the CDCN through their purchases with AmazonSmile, at no cost to you. When you shop at AmazonSmile, you’ll find the exact same low prices, vast selection and convenient shopping experience as usual with Amazon, with the added bonus that Amazon will donate a portion of the purchase price to your favorite charitable organization. Click here to learn more.

On your first visit to AmazonSmile (smile.amazon.com), you will need to select "Castleman's Awareness & Research Effort" (CDCN's official legal name) to have donations made from eligible purchases before you begin shopping. Amazon will remember your selection, and then every eligible purchase you make at smile.amazon.com will result in a donation to CDCN!

JOIN THE FIGHT, DONATE TODAY!
We have made incredible progress, but have life saving work that needs funding. With your support we can beat Castleman Disease! Click here to donate! 

Facebook
Facebook
Website
Website
Twitter
Twitter
YouTube
YouTube
Donate
Donate
Copyright © 2016 CDCN, All rights reserved.

unsubscribe from this list    update subscription preferences